Rob Berg work email
- Valid
- Valid
- Valid
Rob Berg personal email
I am an M.D., Ph.D. with a broad medical, academic and life science industry background and with an intense focus on drug discovery and development in Oncology. My working life experience includes experimental academic research, medical practice and 23 years in biotech and pharmaceutical industry in senior positions in translational medicine and clinical development.I have extensive hands-on experience with all phases of drug development and possess a broad knowledge of drug discovery and development principles and practice with an emphasis on early clinical research and the opportunities and risks with Proof-of-Concept projects. I have a proven track record as a successful leader of cross-functional teams from my previous positions as Director Translational Medicine at Merck/MSD, Director Clinical Research at Organon, and Medical Advisor at Genzyme. I have originally been trained as a molecular biologist and as a physician. My academic research has mostly focused on melanoma and non-melanoma skin cancer and has resulted in >30 publications.Specialties: Oncology drug development;Translational medicine;Medical Monitoring of oncology studies;Biomarker-based decision making;Leadership of cross-functional teams;Proof-of-Concept strategies in drug development;Public-Private partnerships in drug discovery and development.
Syneos Health
View- Website:
- syneoshealth.com
- Employees:
- 23167
-
Global Medical Lead, OncologySyneos HealthAmsterdam, Nh, Nl
-
Vice President, Medical ManagementSyneos Health Oct 2018 - PresentAmsterdam Area, NetherlandsLeadership role within our global team of 45 medical oncologists and hematologists responsible for medical monitoring and oncology clinical development strategies for our biotech, pharmaceutical, and academic customers.
-
Executive Medical Director OncologySyneos Health (Previously Inc Research/Inventiv Health) Oct 2017 - Sep 2018Amsterdam Area, Netherlands
-
Co-Organizer/Co-Chair Oncology Drug Development In Practice, OddpOncology Drug Development In Practice (Oddp) Nov 2013 - Nov 2021ODDP is a yearly 3-day course in oncology drug development that has been held for 17 times between 2004 and 2021 in the Amsterdam area. The course has been attended by >400 drug development professionals, mostly from European biotech and small pharma companies. Between 2013 and 2021, I have served as co-organizer, co-chair, and presenter.
-
Senior Medical Director OncologyInc Research Jul 2012 - Sep 2017Amsterdam AreaMy key role was providing medical and scientific oversight for oncology clinical development programs in Europe. Also, I served as lead medical monitor to a broad range of clinical studies in oncology. In addition, I participated in customer consultations and bid-defenses as well as in project-specific and therapeutic area training to operational teams. Furthermore, I have provided regulatory consulting on oncology projects and acted as mentor and internal expert to our Oncology Business Unit staff.INC Research merged into Syneos Health in January 2018. -
Sector Coordinator Life Sciences & HealthLygature Sep 2011 - Jun 2012Leiden, South Holland, NetherlandsLife Sciences & Health was an innovation program aimed at promoting open innovation in pharmaceutical R&D by realizing Public-Private collaboration in drug discovery and development. I was responsible for providing coherence in scientific, financial, and IP affairs among five Public-Private consortia (with a total budget of 160 million Euro) and for implementing an optimal organizational framework for the future. The innovation program was part of Top Institute Pharma which merged into Lygature in 2015. -
Director Translational Medicine OncologyMerck Oct 2009 - Sep 2011Responsible for early clinical development strategies in oncology as well as for their implementation by leading clinical development teams, managing CROs, and liaising with external medical opinion leaders. Key goals were to effectively integrate drug discovery with clinical development and to accomplish biomarker-driven Go/No-Go decisions in early clinical development in oncology. Co-chair of global review committee of clinical biomarker development plans. -
Director Clinical Research Internal MedicineOrganon Feb 2006 - Oct 2009Main responsibility was providing strategic direction and leading Proof of Concept teams in the areas of endocrinology, oncology, and anticoagulation. Designed clinical development programs up to Proof-of-Concept for eight innovative investigational drugs. Member of joint management committees supervising the collaborative development of antithrombotics with other (Japanese and French) pharma companies. Organon was acquired by Merck/MSD in November 2009. -
Medical AdvisorGenzyme Aug 2001 - Jan 2006I have lead global Phase IIB/III studies on the therapeutic use of recombinant human TSH (Thyrogen®) in thyroid cancer and have been driving discussions with EMA on the outcomes, resulting in two European label extensions of Thyrogen®. Also, I have managed a compassionate use program for Thyrogen® in metastatic thyroid cancer patients as well as numerous investigator-driven studies to explore novel indications for recombinant human TSH. -
Resident In DermatologyUniversity Medical Center Utrecht Aug 2000 - Jul 2001Practising physician with overall medical responsibility for in-house patients at the dermatology ward. -
Postdoc ScientistUniversity Medical Center Utrecht Nov 1994 - Nov 1998Over 30 (co)authorships in peer-reviewed journals, among which "PNAS", "Cell", "Nature", mainly on the role of DNA repair and tumor suppressor genes in skin cancer development.
Rob Berg Skills
Rob Berg Education Details
-
Ecpm Course In Pharmaceutical Medicine, University Basel -
Medicine -
Skin Cancer
-
Molecular Biology -
Gymnasium Beta, Sint Ursula, Horn
Frequently Asked Questions about Rob Berg
What company does Rob Berg work for?
Rob Berg works for Syneos Health
What is Rob Berg's role at the current company?
Rob Berg's current role is Global Medical Lead, Oncology.
What is Rob Berg's email address?
Rob Berg's email address is ro****@****4all.nl
What schools did Rob Berg attend?
Rob Berg attended European Center For Pharmaceutical Medicine, Utrecht University, Utrecht University, Radboud University Nijmegen, Gymnasium Beta, Sint Ursula, Horn.
What skills is Rob Berg known for?
Rob Berg has skills like Clinical Development, Drug Development, Oncology, Pharmaceutical Industry, Clinical Research, Translational Medicine, Drug Discovery, Cell, Medical Affairs, Pharmacology, Cancer, Endocrinology.
Who are Rob Berg's colleagues?
Rob Berg's colleagues are Viktoriia Miller, Dharmendra Kumar, Namrata Vengurlekar, Chelsea Phillips, Vanessa Arendt, Steve Decoux, Helen Wellard.
Not the Rob Berg you were looking for?
-
2adl.org, bergetiketten.nl
-
1casema.nl
-
1gmail.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial